On 30 May 2016
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2016, to Consider and Approve the Audited financial results for the quarter/year ended 31 March 2016 & to Recommend dividend, if any, for the year ended 31 March 2016.Powered by Capital Market - Live News
